Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma
Anusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
JCO Precision Oncology
|
January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial
Tara A Russell, Mark A Eckardt, Takashi Murakami, et al.
Immunity
|
November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy
Hua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
American Journal of Clinical Oncology
|
April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas
Joseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2023
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1
Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab
Theodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Surgery
|
October 10, 2025
Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients
Mark A Eckardt, Nicholas M Siena, Amy R Copeland, et al.
Nature Cancer
|
February 5, 2022
Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Cancer Research
|
January 14, 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response
Erik S Blomain, Shaghayegh Soudi, Ziwei Wang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma
Anusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
JCO Precision Oncology
|
January 8, 2019
Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial
Tara A Russell, Mark A Eckardt, Takashi Murakami, et al.
Immunity
|
November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy
Hua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
American Journal of Clinical Oncology
|
April 18, 2018
Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas
Joseph Daniel Pennington, Fritz C Eilber, Frederick R Eilber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 3, 2023
Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1
Sharareh Gholamin, Heini M Natri, Yuqi Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2018
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab
Theodore S Nowicki, Beata Berent-Maoz, Gardenia Cheung-Lau, et al.
Surgery
|
October 10, 2025
Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients
Mark A Eckardt, Nicholas M Siena, Amy R Copeland, et al.
Nature Cancer
|
February 5, 2022
Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Cancer Research
|
January 14, 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response
Erik S Blomain, Shaghayegh Soudi, Ziwei Wang, et al.
Page
of 8